Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Acquiring Part of Carestream's Molecular Imaging Business

NEW YORK (GenomeWeb News) – Bruker announced today an agreement to acquire the preclinical in vivo imaging equipment product portfolio and related assets from Carestream Health's Molecular Imaging business for an undisclosed amount.

The deal is expected to be completed in the next several weeks, Bruker said. The majority of employees in the Carestream business being bought by Bruker are being offered employment with Bruker.

"We believe that Carestream's optical molecular imaging product line will complement our other preclinical solutions, presently consisting of magnetic resonance imaging, magnetic particle imaging, and X-ray micro computed tomography," Werner Maas, president of Bruker BioSpin, said in a statement.

Carestream will keep the remaining assets of the Molecular Imaging business, including its life science X-ray film product lines and its Gel Logic and Image Station in vitro imaging equipment product portfolio, though new production of Gel Logic and Image Station in vitro products are being discontinued.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.